BIOCANN LTD
BioCann is a South African medical cannabis cultivator operating the country's largest commercial indoor facility on a 100-hectare Limpopo farm, exporting pharmaceutical-grade flower to licensed partners in Germany, the UK, and Australia under SAHPRA, CUMCS, and pending EU-GMP certifications.
- Company typePrivate
- Founded2019
- HeadquartersCape Town, South Africa
- Headcount1–10
- GTM typeB2B
- OfferingHardware or Manufacturing
What BIOCANN LTD does
BioCann LTD, operating as BioCann (Pty) Ltd, is a South African medical cannabis cultivator founded in 2019 and headquartered in Cape Town, with its principal cultivation and processing operation on a 100-hectare farm in Limpopo province. The company runs what it claims is the largest commercial indoor cannabis facility in South Africa, spanning over 3,500 square meters with capacity to grow at least 50,000 plants annually across seven licensed hectares. Cultivation operates under Good Agricultural and Collection Practice (GACP), processing under Good Manufacturing Practice (GMP), and both facilities hold Control Union Medical Cannabis Standard (CUMCS) certification, with SAHPRA compliance achieved in 2020 as one of the country's first licensed producers.
BioCann's product offering is built on an exclusive genetics partnership with Segra International, a global cannabis plant genetics company, providing Health Canada-registered strains with digital traceability for pharmaceutical-grade consistency. The company has imported EU-GMP equipment and is preparing for inspection to unlock premium European and Australian export markets.
The business model is B2B pharmaceutical export of medical-grade cannabis flower to licensed partners in Germany, the UK, and Australia, supplemented by local South African patient access under Section 21 of the Medicines and Related Substances Act. The company also runs a sponsorship program providing free medical-grade cannabis to cancer patients. Revenue is generated through quote-based B2B pharmaceutical supply contracts; no pricing or revenue figures are publicly disclosed. The leadership team includes a Lead Cultivator with a Master's in Horticulture and a Research Scientist with a Ph.D. in Plant Genetics.
BIOCANN LTD firmographics
Firmographics- Name
- BIOCANN LTD
- Legal name
- BioCann (Pty) Ltd
- Website
- https://bio-cann.com
- Company type
- Private
- Founded year
- 2019
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- BioCann is a South African medical cannabis cultivator operating the country's largest commercial indoor facility on a 100-hectare Limpopo farm, exporting pharmaceutical-grade flower to licensed partners in Germany, the UK, and Australia under SAHPRA, CUMCS, and pending EU-GMP certifications.
- Ownership category
- akta.pro rank
BIOCANN LTD industry classification
Industry- Product category
- Medical Cannabis Cultivation
- NAICS
- Medicinal and Botanical Manufacturing (325411)
- SIC
- Agricultural Production-Crops (100), Medicinal Chemicals & Botanical Products (2833)
- akta.pro primary industry
- Medicinal Plant Farming (Botanical/Pharmaceutical Crops) (AFAGAGAE)
Keywords
Where BIOCANN LTD is headquartered
LocationHeadquarters
- HQ city
- Cape Town
- HQ country
- South Africa
- HQ region
- Africa
Offices2 records
Markets served
BIOCANN LTD business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Operations, Personnel, Supply Chain, Technology or R&D, Marketing or Sales
Revenue model
- Medical Cannabis Export: Export of premium medical cannabis flower and products to international pharmaceutical companies in Germany, UK, and Australia. B2B revenue through pharmaceutical supply relationships.
- Local South African Market: Development of local patient access in accordance with Section 21 of Medicines and Related Substances Act 101 of 1965. Also provides medical-grade cannabis free of charge to local cancer patients through sponsorship program.
Go-to-market motion2 records
Distribution channels2 records
Marketing channels4 records
BIOCANN LTD product offering
Product offeringCore offering
BioCann cultivates, processes, and supplies medical-grade cannabis from a 3,500 square meter indoor facility on a 100-hectare farm in Limpopo Province, South Africa. The company operates seven licensed hectares with capacity to grow at least 50,000 cannabis plants annually, exporting premium flower to international pharmaceutical companies in Germany, the UK, and Australia while supporting local patient access under Section 21 of the Medicines and Related Substances Act.
Product overview
BioCann is a medical cannabis cultivator offering a vertically integrated service portfolio centered on premium medical cannabis cultivation. The core offerings include Premium Medical Cannabis Cultivation (indoor facility spanning 3,500+ square meters, growing 50,000+ plants annually) and Medical Grade Supply products, with both cultivation and processing facilities certified under GACP and GMP standards respectively. All products are powered by genetics partnership with Segra International. The company exports to Germany, UK, and Australia while developing the local South African medical cannabis market.
Differentiator
Problem solved
Functional benefit
Products and services
- Premium Medical Cannabis Cultivation Indoor cannabis cultivation services producing premium strains that exceed global quality standards, supplied to international pharmaceutical companies and export markets including Germany, UK, and Australia.
- Medical Grade Supply Medical-grade cannabis products meeting stringent quality standards, providing reliable premium products for medical use by licensed pharmaceutical and medical partners.
- Cannabis Cultivation Services Indoor cultivation facility spanning over 3,500 square meters capable of growing at least 50,000 cannabis plants annually, operating under Good Agricultural and Collection Practice (GACP) standards.
- Cannabis Processing Services Processing facility managed under Good Manufacturing Practice (GMP) standards, certified under the Control Union Medical Cannabis Standard (CUMCS) for post-cultivation processing of medical cannabis.
Quantifiable outcome
- 610+ trusted clients
- +2 more outcomes
Companies that use BIOCANN LTD
Customer profileNamed customers5 records
Segments2 records
Ideal customer profiles2 records
BIOCANN LTD technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
BIOCANN LTD partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Segra InternationalcoreBioCann's product offering is uniquely powered by its partnership with Segra International – a global leader in cannabis plant genetics. Equipped with superior strains and combined with BioCann's extensive knowledge and innovative technology, this partnership ensures production of exceptional medical cannabis products.
Scale indicators7 records
Recent moves6 records
Expansion highlights6 records
BIOCANN LTD competitors and assessment
Company assessmentBroad incumbents
- Aurora Cannabis: Canadian cannabis major with EU GMP-certified production and international medical cannabis distribution. Operates in overlapping product/customer categories as BioCann but at much larger scale.
- Canopy Growth: Canadian cannabis major with international medical cannabis operations and European distribution. Comparable industry positioning to BioCann but as a diversified incumbent with significantly broader product portfolio.
- OrganiGram Holdings: Canadian medical cannabis producer with international supply capabilities and pharmaceutical partnerships. Comparable medical-grade cultivation focus though with broader product range and established capital markets access.
- Tilray: Major international cannabis producer with EU GMP-certified operations and established pharmaceutical supply relationships across Germany and other European markets. Overlaps with BioCann's medical cannabis export business but operates at much larger scale.
- Cronos Group: International cannabis operator with medical-grade production and global distribution. Comparable in international medical cannabis positioning though at significantly larger scale and broader geographic footprint.
Direct peers
- MediPharm Labs: Canadian GMP-certified cannabis extracts manufacturer supplying pharmaceutical partners internationally. Comparable to BioCann in its GMP-certified processing focus and B2B pharmaceutical channel strategy.
- Clever Leaves: Colombian-based medical cannabis cultivator with EU GMP-certified operations and a B2B export model targeting European pharmaceutical buyers. Closely comparable to BioCann's vertical integration, EU GMP focus, and international export strategy.
- Khiron Life Sciences: Latin American medical cannabis cultivator with established European distribution and a pharmaceutical-aligned B2B model. Comparable to BioCann in its cultivation-to-pharma-export approach and regulatory positioning for premium markets.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks5 records
Key highlights5 records
Customer concentration
BIOCANN LTD social profiles
Digital presenceBIOCANN LTD compliance and trust
Trust signalCompliance4 records
BIOCANN LTD financial estimates
Financial estimateRevenue estimate
Valuation estimate
BIOCANN LTD leadership team
Management profileNumber of profiles
Profiles2 records
BIOCANN LTD funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
BIOCANN LTD M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about BIOCANN LTD
What does BIOCANN LTD do?
BioCann cultivates, processes, and supplies medical-grade cannabis from a 3,500 square meter indoor facility on a 100-hectare farm in Limpopo Province, South Africa. The company operates seven licensed hectares with capacity to grow at least 50,000 cannabis plants annually, exporting premium flower to international pharmaceutical companies in Germany, the UK, and Australia while supporting local patient access under Section 21 of the Medicines and Related Substances Act.
Is BIOCANN LTD a public or private company?
BIOCANN LTD is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was BIOCANN LTD founded?
BIOCANN LTD was founded in 2019. It employs 1 to 10 people.
Where is BIOCANN LTD based?
BIOCANN LTD is headquartered in Cape Town, South Africa, in the Africa region.
How does BIOCANN LTD make money?
Two revenue lines are on record. Medical Cannabis Export is the primary driver. The others are local South African Market.
Who are BIOCANN LTD's main competitors?
Broad incumbents on record are Aurora Cannabis, Canopy Growth, OrganiGram Holdings, Tilray and Cronos Group. Direct peers are MediPharm Labs, Clever Leaves and Khiron Life Sciences.
Does BIOCANN LTD have an API?
No public API is recorded for BIOCANN LTD.
What industry is BIOCANN LTD in?
BIOCANN LTD's product category is Medical Cannabis Cultivation. Its primary akta.pro industry code is AFAGAGAE, Medicinal Plant Farming (Botanical/Pharmaceutical Crops). Its NAICS code is 325411 and its SIC code is 100.